Adjuvant Therapy | 2023 Best of Breast Conference

Triple Negative Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference

HER2+ MBC | 2023 Best of Breast Conference

Estrogen Receptors & HER2/neu Receptors in Breast Cancer (a TUTORIAL from Oster Oncology)

2021 Evolution Kansas City | Case 3: DCIS /Early Stage

Managing the Side Effects of Aromatase Inhibitors and Tamoxifen

Cancer Risks, Screening & Prevention for People w/ ATM, CHEK2, PALB2 & Other Genes by A. Kurian, MD

Updates Rectal Cancer | 2023 Best of GI Cancer Conference

Hormone Receptor-Positive and HER2-Positive Breast Cancer: A Medical Update

Diversity, Inclusion, and Equity in Cancer Care | 2023 Best of Breast Conference

ER+ Breast Cancer Case Panel Discussion | 2022 Best of Breast Conference

Understanding Your Breast Cancer Pathology Report

ctDNA and MRD | 2023 Best of GI Cancer Conference

Medical update: HER2-Positive and triple-positive metastatic breast cancer

Tamoxifen & Aromatase Inhibitors: How to Tolerate them for best results!

Западная онкологическая конференция 2022 г. | Рак молочной железы | Ранняя стадия

Bone mets

Лечение инвазивной дольковой карциномы HR+ — OncBrothers (Рохит и Рахул Госейн) с доктором Джейсо...

Ask the expert: Hormone receptor-positive breast cancer

Breast Cancer Breakout: Rapid research developments and new treatment combinations

Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference